Oncology

Carlos Caldas | Clinician Scientist and Senior Group Leader, Cancer Research UK Cambridge Institute; Chair of Medicine…

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…

Lung cancer has a devastating global impact, claiming almost 2 million lives in 2020.1 Despite advances in treatment, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.

Thyroid cancer is the most common malignant endocrine tumour in the world, but it only accounts for 1% of all cancers…

The two most common EGFR mutations differ in their kinase domain structures at different sites, resulting in differential sensitivity to EGFR

NF1 is an autosomal dominant disorder, arising from a mutation in the gene that encodes neurofibromin. It is a tumour-predisposing…

Neurofibromatosis Type 1 (NF1) is a rare disease, occurring in approximately 1 in 3,000 people. Among the numerous manifestations…

The management of patients with cancer is complex and requires contribution from a range of healthcare professionals working alongside specialist oncology consultants to address patients’ needs and optimise outcomes.